A dual apolipoprotein C-II mimetic–apolipoprotein C-III antagonist peptide lowers plasma triglycerides
Sign Up to like & getrecommendations! Published in 2020 at "Science Translational Medicine"
DOI: 10.1126/scitranslmed.aaw7905
Abstract: An apolipoprotein C-II peptide mimetic for the treatment of hypertriglyceridemia activates lipoprotein lipase and blocks apolipoprotein C-III. How low can you go? People with elevated plasma triglycerides face increased risk of cardiovascular disease. Wolska et… read more here.
Keywords: d6pv; apoc; plasma triglycerides; apolipoprotein iii ... See more keywords